| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 18,252 | 19,355 | 15,347 | 34,190 | | Cost of Revenue | 21,736 | 21,313 | 18,205 | 25,443 | | | Gross Profit | (3,484) | (1,958) | (2,858) | 8,747 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 3,913 | 4,344 | 4,667 | 7,033 | | Non Recurring | 332 | 1,676 |
-
| 83,811 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (7,729) | (7,978) | (7,525) | (82,097) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (7,796) | (8,064) | (7,587) | (89,358) | | Interest Expense | 1,632 | 1,713 | 1,837 | 1,260 | | Income Before Tax | (9,428) | (9,777) | (9,424) | (90,618) | | Income Tax Expense | (617) |
-
| (830) | (12,199) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (9,026) | (9,777) | (8,594) | (78,419) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (8,811) | (9,777) | (8,594) | (78,419) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($8,811) | ($9,777) | ($8,594) | ($78,419) |
|
0.51% Nasdaq 
Income Statement
